To access all features of this site, you must enable Javascript. Here are the instructions for enabling Javascript in your web browser.
innovation for industry
News | Institutional
News
Liste de actualités du Leti
The CEA, Grenoble Alpes University Hospital, Grenoble Alpes University and Boston Scientific Corporation, a leading company in medical devices, have started on the Near Infra Red (NIR) project clinical trial in March 2021.
REFINE is a Research and Innovation Action to refine the current regulatory scientific framework for nano(bio)material-based medicinal products and medical devices. It will identify, design and test new characterization assays for enhanced regulatory assessment of innovative nanomedicines and biomaterials
The aim of the NEW DEAL initiative is to design the next generation of biological therapy for inflammatory bowel diseases. These immune disorders of the gut, including Crohn’s disease and ulcerative colitis, are chronic with an early onset in life, typically in adolescents and in young adults. These diseases decrease quality of life and can lead to life threatening complications (bowel perforation, cancer...).
LUMINT technology is an innovative diagnostic tool that implements imaging technology and artificial intelligence. The project aim is to identify automatically bacterial pathogens and help clinicians in their therapeutic decisions. The LUMINT@CLINICS project aims to transfer this technology from the laboratory to the hospital.
EUNCL is the European reference Nanomedicine Characterization Laboratory performing full physical, chemical and biological characterization of nanomedicinal products before regulatory application. The full characterization assay cascade has been permanently updated with regulators in response to needs. Thirty-plus nanomedicinal products were accepted by EUNCL between 2016 and 2019.
Children living with Type 1 diabetes have to sustain the burden of frequently checking their glycaemia (for meals and physical activity). The D4Kids project has developed a medical device for regulating insulin delivery in real time that is tailored to these children’s needs. The system allows remote monitoring by parents.
The strategy adopted for protecting pancreatic islets from immune rejection is to microencapsulate them in soft, porous, biocompatible microcapsules. CEA-Leti was project coordinator and leader for microcapsule production, characterisation, dissemination and planned usage.
Project's description
CEA-Leti, a CEA Tech institute, is part of a consortium led by Sequans that is gearing up to deploy 5G for critical IoT applications requiring reliable, low-latency communications.
Imaging has already been revolutionizing medical diagnosis for over four decades. CEA-Leti, which produced and installed the first French scanner in 1976, has been working tirelessly to develop equipment offering increasingly advanced performances.
The EU H2020 Hilico project, which CEA Tech institute CEA-Leti is coordinating, will result in the development of a GaN color microdisplay that delivers excellent resolution and very high brightness.
CEA-Leti is engaged in the EIT Exuchek project, which addresses this issue. The institute is developing a comprehensive CAL monitoring system that will include a device that can be integrated into the surgical drain, an algorithm to trigger alerts at certain thresholds, and a user interface for caregivers.
Kalray, a CEA-Leti spinoff founded in 2008 and publicly traded since 2018, recently raised €5.2 million in fresh capital. The company, which designs multicore, massively parallel microprocessors has now raised a total of €97 million.
The French government announced it has selected the iMRC cybersecurity project to receive funding under the nation’s economic stimulus program. The project aims to improve the cybersecurity of IoT devices whose vulnerabilities could jeopardize network security.
GRENOBLE, France – March 18, 2021 – CEA-Leti scientists have developed a lensless, infrared spectral-imaging system for medical diagnostics. The first application is cancer detection in the tissue section and the second is the identification and discrimination of microorganisms, such as bacteria. Presented in two papers at the Photonics West 2021 Digital Forum, the label-free technology also could eliminate sample preparation in a reliable and user-friendly device that may foretoken automation of some diagnostics.
The ASCENT+ access programme launches a new phase to become the powerhouse of researchers and innovators in nanoelectronics in Europe
GRENOBLE, France – March 11, 2021 – Expanding on its previous advances in integrated optics and silicon photonics, CEA-Leti presented four related papers at Photonics West 2021 Digital Forum that show key steps toward improved AR capabilities with retinal projection.
GRENOBLE, France – March 8, 2021 – Taking a critical step toward developing LiDAR systems for widespread commercial applications, CEA-Leti has developed genetic algorithms to calibrate high-channel-count optical phased arrays (OPAs), as well as an advanced measurement setup enabling wafer-scale OPA characterization.
GRENOBLE, France – March 2, 2021 – CEA-Leti, a technology research institute of CEA Tech, will present 14 papers during Photonics West 2021, March 6-11, including an invited paper, "Advanced roughness characterization for 300mm Si photonics patterning & optimization".
Top page
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.